Active ingredient
Cytarabine NDC Codes
Cytarabine is an active ingredient in 15 finished products listed with the FDA, under 2 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Cytarabine, Vyxeos
- Labelers
- Hospira, Inc., Meitheal Pharmaceuticals Inc., Sagent Pharmaceuticals, Gland Pharma Limited, Jazz Pharmaceuticals, Inc., Fresenius Kabi USA, LLC
- Strengths
- Cytarabine 20 mg/mL; Cytarabine 100 mg/mL; Cytarabine 2 g/20mL; Cytarabine 100 mg/20mL; Daunorubicin 44 mg/20mL
- Dosage forms
- Injection, Solution, Injection, Powder, Lyophilized, For suspension
- Routes
- Intravenous, Subcutaneous, Intrathecal
- Drug classes (FDA established)
- Nucleoside Metabolic Inhibitor, Anthracycline Topoisomerase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 16
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Cytarabine | Cytarabine 100 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Hospira, Inc. | 61703-155 | 61703-0155-01 | — |
| cytarabine | Cytarabine 100 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Sagent Pharmaceuticals | 25021-223 | 25021-0223-20 | — |
| cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Sagent Pharmaceuticals | 25021-229 | 25021-0229-05 | — |
| Cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntravenous, Subcutaneous | Meitheal Pharmaceuticals Inc. | 71288-169 | 71288-0169-25 | — |
| Cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Meitheal Pharmaceuticals Inc. | 71288-108 | 71288-0108-06 | — |
| Cytarabine | Cytarabine 100 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Gland Pharma Limited | 68083-337 | 68083-0337-01 | — |
| Cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Gland Pharma Limited | 68083-343 | 68083-0343-05 | — |
| Cytarabine | Cytarabine 2 g/20mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Meitheal Pharmaceuticals Inc. | 71288-109 | 71288-0109-20 | — |
| Cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntravenous, Subcutaneous | Meitheal Pharmaceuticals Inc. | 71288-168 | 71288-0168-50 | — |
| Vyxeos(daunorubicin and cytarabine) liposome | Cytarabine 100 mg/20mL; Daunorubicin 44 mg/20mL | Injection, Powder, Lyophilized, For suspensionIntravenous | Jazz Pharmaceuticals, Inc. | 68727-745 | 68727-0745-0168727-0745-02 | — |
| Cytarabine | Cytarabine 100 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-120 | 63323-0120-20 | — |
| Cytarabine | Cytarabine 100 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Hospira, Inc. | 61703-319 | 61703-0319-22 | — |
| Cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntravenous, Subcutaneous | Hospira, Inc. | 61703-304 | 61703-0304-36 | — |
| Cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 61703-303 | 61703-0303-46 | — |
| Cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Hospira, Inc. | 61703-305 | 61703-0305-38 | — |
Cytarabine: common questions
- Which drugs contain Cytarabine?
- Cytarabine, Vyxeos.
- Is there a J-code for Cytarabine?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.